An Act to amend the Patent Act (patented medicines)

This bill was last introduced in the 37th Parliament, 1st Session, which ended in September 2002.


Dan McTeague  Liberal

Introduced as a private member’s bill. (These don’t often become law.)


Not active, as of May 1, 2002
(This bill did not become law.)


All sorts of information on this bill is available at LEGISinfo, provided by the Library of Parliament. You can also read the full text of the bill.

Patent ActRoutine Proceedings

May 1st, 2002 / 3:30 p.m.
See context


Dan McTeague Liberal Pickering—Ajax—Uxbridge, ON

moved for leave to introduce Bill C-454, an act to amend the Patent Act (patented medicines).

Mr. Speaker,with Canadians being concerned about the high price of drugs, the bill is intended to repeal provisions of the Patent Act, patented medicines, that enable brand name pharmaceutical manufacturers to initiate automatic injunctions against generic drug companies for alleged patent infringement. Of course under the current regulations a brand name pharmaceutical manufacturer can claim there has been infringement on its drug patent without the need for evidence to suggest that it has actually occurred. This is unique not only in terms of most nations around the world but indeed under the Patent Act. The bill is intended to repeal just that.

(Motions deemed adopted, bill read the first time and printed)